TRACT Therapeutics

Tract Therapeutics

Biotechnology, 1445 W Henderson St, Chicago, Illinois, 60657, United States, 1-10 Employees

tracttherapeutics.com

  • LinkedIn

phone no Phone Number: 13*********

Who is TRACT THERAPEUTICS

TRACT Therapeutics, Inc. has developed a novel approach for restoring immune balance in patients receiving a solid organ transplant or in patients suffering from an autoimmune disease. Th...

Read More

map
  • 1445 W Henderson St, Chicago, Illinois, 60657, United States Headquarters: 1445 W Henderson St, Chicago, Illinois, 60657, United States
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: Under $1 Million

industries-icon Industry: Biotechnology

SIC SIC Code: 8731

checked-icon Does something look wrong? Fix it. | View contact records from TRACT THERAPEUTICS

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding TRACT Therapeutics

Answer: TRACT Therapeutics's headquarters are located at 1445 W Henderson St, Chicago, Illinois, 60657, United States

Answer: TRACT Therapeutics's phone number is 13*********

Answer: TRACT Therapeutics's official website is https://tracttherapeutics.com

Answer: TRACT Therapeutics's revenue is Under $1 Million

Answer: TRACT Therapeutics's SIC: 8731

Answer: TRACT Therapeutics has 1-10 employees

Answer: TRACT Therapeutics is in Biotechnology

Answer: TRACT Therapeutics contact info: Phone number: 13********* Website: https://tracttherapeutics.com

Answer: TRACT Therapeutics, Inc. has developed a novel approach for restoring immune balance in patients receiving a solid organ transplant or in patients suffering from an autoimmune disease. This therapeutic approach may potentially reduce the chance of organ rejection following a transplant or transfer a patient suffering from an autoimmune disease into a state of remission. The proprietary technology is based on a platform which can be utilized to treat solid organ transplant patients, as well as a number of autoimmune disorders such as Crohns Disease. For organ transplant, it shows great promise in preventing rejection of a donated organ, thereby, reducing the need for a second transplant. Over the next few years, TRACTs TregCelTM personalized therapy could transform the medical approach in transplant medicine by dramatically reducing or eliminating the lifelong use of toxic anti-rejection drugs.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access